In conclusion, the heterogeneous nature of AD encompasses many aspects, including genetic factors, core biomarkers in CSF and disease trajectories. While core pathologies of AD include amyloid plaques and neurofibrillary tangles, patients differ in other ongoing disease processes, which may require personalized therapies.
More information on the thesis